Searchable abstracts of presentations at key conferences in endocrinology

ea0063p241 | Pituitary and Neuroendocrinology 1 | ECE2019

Long-term results of bilateral adrenalectomy in a patient with cyclic Cushing’s syndrome

Concepcion Terroba Larumbe Maria , Maria Palacio Mures Jose , Crespo Soto Cristina , Angel Citores Pascual Miguel , Benito Fernandez Cesar , Calero Aguilar Hermogenes , Anacabe Goyogana Itciar , Ventosa Vina Marta , Cuellar Olmedo Luis

Introduction: Cyclic Cushing’s Syndrome (CCS) is a rare disorder in which rhythmic fluctuations in the secretion of ACTH trigger cyclic variations in the production of adrenal steroids and an extremely variable clinical presentation. It should be considered when clinical hypercortisolism coexists with normal cortisol levels and a paradoxical response to the dexamethasone test, and when selective transsphenoidal adenomectomy fails after an uncomplicated intervention.<p...

ea0063p243 | Pituitary and Neuroendocrinology 1 | ECE2019

Papillary thyroid carcinoma in acromegalic patient diagnosed with McCune Albright syndrome (MAS)

Concepcion Terroba Larumbe Maria , Crespo Soto Cristina , Maria Palacio Mures Jose , Acuna Garcia Manuel , Mendo Gonzalez Marcelino , Ventosa Vina Marta , Cuellar Olmedo Luis , De las Heras Florez Paula , Anacabe Goyogana Itciar

Introduction: McCune Albright syndrome (MAS) is a rare, sporadic disease that affects the skin, skeleton and several endocrine systems, caused by an activating mutation in the GNAS gene that leads to endocrine cell hyperfunction and increased cell proliferation. The development of thyroid carcinoma in MAS is considered an uncommon event and, on the other hand, it is well established that acromegaly is associated with an increased prevalence of malignant tumors including thyroi...

ea0070aep625 | Pituitary and Neuroendocrinology | ECE2020

Malignant insulinoma treated with 177Lu-DOTATATE: Results in the first year post-therapy

Concepción Terroba-Larumbe María , Maria Palacio-Mures Jose , Crespo-Soto Cristina , Perez-Saborido Baltasar , Crespo-Herrero Guillermo , Ventosa-Viña Marta , Acuña-Garcia Manuel , Alejo-Ramos Mirian , Anacabe-Goyogana Itziar , Cuellar-Olmedo Luis

Introduction: Neuroendocrine tumors (NETs) are rare and their clinical behavior and prognosis correlates with mitotic rate and Ki-67 index. Most patients with advanced NET have liver metastases unresectable and somatostatin analogues are the initial therapy of choice but when disease progresses despite treatment and there are positive somatostatin receptors, peptide receptor radioligand therapy (PRRT), using lutetium-177, is a therapeutic option.Clinical...